Gyre Therapeutics GYRE
NASDAQ GYRE
$5.90 -0.27 (-4.38%)
At close: Oct 21, 2026 · 4:00 PM EDT

Gyre Therapeutics (GYRE) Total Non-Current Liabilities (2014 - 2026)

Updated

Gyre Therapeutics (GYRE) posted Total Non-Current Liabilities of $54.03 million for Q2 2026, down 39.9% from $89.84 million a year earlier and down 53.4% from the prior quarter.

Analysis

Gyre Therapeutics (GYRE) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends

At the end of FY2025, Gyre Therapeutics' Total Non-Current Liabilities came in at $154.31 million, up 83.8% from FY2024.

  • Annual Total Non-Current Liabilities shows a three-year compound annual growth rate of 131.2% (FY2022 to FY2025).
  • In prior years, Gyre Therapeutics' Total Non-Current Liabilities was $83.95 million in FY2024 (-6.5%), $89.76 million in FY2023 (+619.1%) and $12.48 million in FY2022.
  • Quarterly Total Non-Current Liabilities has run from a low of $12.48 million in Q4 2022 to a high of $154.31 million in Q4 2025 over five years.
  • On a year-over-year basis, Total Non-Current Liabilities increased in four of the last seven quarters, with growth averaging 88.4%.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q4 2023, with growth of 619.1%; the weakest was Q2 2026, with a decline of 39.9%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $116.06 million (Q1 2026), $154.31 million (Q4 2025) and $18.75 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 105.50 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 106.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 33.91 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.10 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 97.04 Bn
10 Gyre Therapeutics 592.25 Mn 360.40 Mn 26.90 Mn 53.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 53.96 Mn
Mar 31, 2026 114.60 Mn
Dec 31, 2025 152.80 Mn
Sep 30, 2025 17.32 Mn
Jun 30, 2025 88.41 Mn
Mar 31, 2025 84.30 Mn
Dec 31, 2024 83.94 Mn
Sep 30, 2024 20.90 Mn
Jun 30, 2024 21.90 Mn
Mar 31, 2024 24.64 Mn
Dec 31, 2023 89.71 Mn
Dec 31, 2022 12.48 Mn
Dec 31, 2018 4.80 Mn
Sep 30, 2018 3.30 Mn
Jun 30, 2018 2.44 Mn
Mar 31, 2018 2.90 Mn
Dec 31, 2017 8.74 Mn
Dec 31, 2016 22.01 Mn
Sep 30, 2016 31.99 Mn
Jun 30, 2016 33.71 Mn
API Access

Gyre Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GYRE&period=max&api_key=YOUR_API_KEY